Results 201 to 210 of about 3,524,198 (392)

Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Tacrolimus is a cornerstone immunosuppressant in transplantation medicine with a narrow therapeutic window. Drug–drug interactions with strong CYP3A4 and P‐glycoprotein modulators, such as rifampin and azole antifungals, significantly alter tacrolimus exposure and complicate therapy. Two transplant cases illustrates the impact of rifampin on tacrolimus
Jeroen P. A. Houwen   +6 more
wiley   +1 more source

Development of a novel family of antifungal agents based on a quinone methide oxime framework. [PDF]

open access: yesSci Rep
Janeczko M   +14 more
europepmc   +1 more source

Fungal Diseases in Elasmobranchs and Their Possible Treatment with a Special Mention to Azole Antifungal Agents. [PDF]

open access: yesAnimals (Basel), 2023
Cañizares-Cooz D   +5 more
europepmc   +1 more source

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients [PDF]

open access: bronze, 1999
Mónica Chávez   +5 more
openalex   +1 more source

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

open access: yesBMEMat, EarlyView.
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah   +9 more
wiley   +1 more source

Synthesis, characterization and bio-evaluation of novel series of pyrazoline derivatives as potential antifungal agents. [PDF]

open access: yesSci Rep
Yadav CS   +11 more
europepmc   +1 more source

Restricticin, a novel glycine-containing antifungal agent.

open access: bronze, 1991
Robert E. Schwartz   +15 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy